N.A. Mark Estes
American Association for Thoracic Surgery
Network
Latest external collaboration on country level. Dive into details by clicking on the dots.
Publication
Featured researches published by N.A. Mark Estes.
Circulation | 2012
Cynthia M. Tracy; Andrew E. Epstein; Dawood Darbar; John P. DiMarco; Sandra B. Dunbar; N.A. Mark Estes; T. Bruce Ferguson; Stephen C. Hammill; Pamela Karasik; Mark S. Link; Joseph E. Marine; Mark H. Schoenfeld; Amit J. Shanker; Michael J. Silka; Lynne W. Stevenson; William G. Stevenson; Paul D. Varosy
Developed in Collaboration With the American Association for Thoracic Surgery, Heart Failure Society of America, and Society of Thoracic Surgeons
Archive | 2002
Eric Rashba; Mark S. Link; N.A. Mark Estes
The hereditary long QT syndrome (LQTS) is a rare disorder characterized by prolongation of the QT interval on the electrocardiogram (ECG) and a propensity for syncope, torsades de pointes, ventricular arrhythmias, and sudden death. One form of LQTS, described by Jervell and Lange-Neilsen in 1957, is characterized by deafness and autosomal recessive inheritance (1). The most common form of LQTS was initially described by Romano (2) and Ward (3), and is characterized by autosomal dominant inheritance and normal hearing. Remarkable progress has been made in the last several years in our understanding of the pathogenesis of LQTS. It is now clear that LQTS is a heterogeneous disorder caused by mutations in specific ion channels that play a critical role in the control of cardiac repolarization (4). These findings have revolutionized our understanding of LQTS, and may yield new insights into other conditions characterized by ventricular arrhythmias in the absence of ischemia or structural heart disease. Recent work has also identified LQTS as an important cause of sudden infant death syndrome (SIDS) (5,6).
Archive | 2001
Munther K. Homoud; Craig Swygman; Mark S. Link; Caroline Foote; N.A. Mark Estes; Paul J. Wang
Radiofrequency ablation has become a major therapeutic modality in the treatment of cardiac arrhythmias. Most forms of supraventricular tachycardia have been successfully treated with catheter-based techniques using focal ablative radiofrequency lesions. A large range of other arrhythmias, however, may be treated using longer, wider, and deeper lesions. A long linear lesion may be particularly important in the ablation of reentrant arrhythmias that have a critical zone 1-cm or more in length. Such a critical zone may exist between two or more anatomic structures, such as in atrial flutter, scar-related reentrant tachycardias, some atrial tachycardias, and some ventricular tachycardias (Figure 1). A series of linear lesions may also be effective in preventing perpetuation of reentrant wavefronts in such disorders as atrial fibrillation (Figure 2). A line of lesions may be placed circumferentially when it is not possible or desirable to ablate the arrhythmia focus itself (Figure 3). This approach may be useful in some ventricular tachycardias and in focal atrial fibrillation ablation in pulmonary veins. There are situations in which the reentrant circuit may be complex and it is not possible to ablate all the critical zones. It may be possible to transect the zone in such cases as ischemic-based ventricular tachycardia (Figure 4). Wide lesions may be necessary when the reentrant circuit spans a large surface area subendocardial (Figure 5).
Syncope: Mechanisms and Management, Second Edition | 2007
Olaf Hedrich; Mark S. Link; Munther K. Homoud Md and; N.A. Mark Estes
Cardiac Electrophysiology: From Cell to Bedside (Seventh Edition) | 2018
Mark S. Link; N.A. Mark Estes
Archive | 2012
Ann C. Garlitski; Munther K. Homoud; N.A. Mark Estes
/data/revues/08947317/v8i3/S0894731705800513/ | 2011
Alain Delabays; Natesa Pandian; Qi-Ling Cao; Lissa Sugeng; N.A. Mark Estes; Paul J. Wang
New Arrhythmia Technologies | 2007
Jonathan Weinstock; Munther K. Homoud; Mark S. Link; N.A. Mark Estes
Diagnosis and Management of Hypertrophic Cardiomyopathy | 2007
N.A. Mark Estes; Paul J. Wang; Munther K. Homoud; Mark S. Link
Diagnosis and Management of Hypertrophic Cardiomyopathy | 2007
Mark S. Link; N.A. Mark Estes; Barry J. Maron